Abstract
Technologic advances have enhanced clinical understanding of the physical changes that occur in the vasculature during atherosclerosis development. Traditionally, diagnostic techniques such as angiography have focused on the lumen of the coronary arteries, with narrowing of the lumen suggesting the presence of atherosclerotic plaques in the vessel wall. Newer methods, such as intravascular ultrasound, focus on the vessel wall itself and have shown that extensive plaque development can occur in conjunction with minimal luminal restriction of the artery. In fact, lumen narrowing occurs only in the very late stages of atherosclerosis, suggesting that, in many cases, the early stages of disease development would remain undetected when angiographic techniques are used. The ability to detect atheromatous disease, particularly in the early stages of development, must be accompanied by systemic pharmacologic therapies effective in inducing atherosclerotic regression. With this in mind, a recent study in patients treated with statins has shown less progression with aggressive lipid lowering, while the findings from trials employing peroxisome proliferator‐activated receptor‐γ agonists are eagerly awaited.
Keywords: intravascular ultrasound, atherosclerosis, regression, statins, thiazolidinediones
Full Text
The Full Text of this article is available as a PDF (564.9 KB).
References
- 1. National Diabetes Data Group : Diabetes in America, 2nd edition Bethesda, Md: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995. [Google Scholar]
- 2. Nissen SE: Application of intravascular ultrasound to characterize coronary artery disease and assess the progression or regression of atherosclerosis. Am J Cardiol 2002; 89 (4A): 24B–31B [DOI] [PubMed] [Google Scholar]
- 3. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ: Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316: 1371–1375 [DOI] [PubMed] [Google Scholar]
- 4. Koshiyama H, Shimono D, Kuwamura N, Minamikawa J, Nakamura Y: Rapid communication: Inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes. J Clin Endocrinol Metab 2001; 86: 3452–3456 [DOI] [PubMed] [Google Scholar]
- 5. Nissen SE, Tsunoda T, Tuzcu EM, Schoenhagen P, Cooper CJ, Yasin M, Eaton GM, Lauer MA, Sheldon WS, Grines CL, Halpern S, Crowe T, Blankenship JC, Kerensky R: Effect of recombinant ApoA‐1 Milano on coronary atherosclerosis in patients with acute coronary syndromes: A randomized controlled trial. J Am Med Assoc 2003; 290: 2292–2300 [DOI] [PubMed] [Google Scholar]
- 6. Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN: Effect of intensive compared with moderate lipid‐lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. J Am Med Assoc 2004; 291: 1071–1080 [DOI] [PubMed] [Google Scholar]